• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Eaton Vance Ohio Municipal Income Trust (NQ: EVO )

    3.100 -0.100 (-3.13%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 105,186
    Open 3.130
    Bid (Size) 3.060 (15)
    Ask (Size) 3.450 (1)
    Prev. Close 3.200
    Today's Range 3.090 - 3.140
    52wk Range 2.850 - 12.40
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability'
    Evotec reports a rise in Q2 sales to $201.12M but posts an EPS loss of $0.54. CEO Christian Wojczewski cites market challenges and outlines cost-cutting measures, including a 7% workforce reduction. 
    Via Benzinga
    Topics Workforce
    Exposures Layoff
    EVO Stock Earnings: Evotec Misses EPS, Misses Revenue for Q2 2024
    EVO stock results show that Evotec missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -72.81%
    -72.81%
    1 Month
    -36.99%
    -36.99%
    3 Month
    -40.04%
    -40.04%
    6 Month
    -57.77%
    -57.77%
    1 Year
    -72.00%
    -72.00%

    More News

    Read More
    Evotec SE Reports H1 2024 Results: Challenging Year; Priority Reset for Sustainable Profitable Growth Gaining Momentum, Building on Core Strengths
    Via ACCESSWIRE
    Evotec Announces Strong Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb
    Via ACCESSWIRE
    Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
    Via ACCESSWIRE
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Evotec SE Provides Guidance Update
    Via ACCESSWIRE
    Evotec Provides Guidance Update
    Via ACCESSWIRE
    Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Evotec SE Reports First Half-year 2024 Results on 14 August 2024
    Via ACCESSWIRE
    Delta Air Lines Posts Downbeat Earnings, Joins United Airlines, American Airlines And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    Evotec and Pfizer Collaborate to Advance Drug Discovery in France
    Via ACCESSWIRE
    Just - Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz
    Via ACCESSWIRE
    Evotec Reports Q1 2024 Results and Provides Corporate Update
    Via ACCESSWIRE
    Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
    Via ACCESSWIRE
    German Drug Developer Evotec Seeks Adviser Input As Takeover Concerns Mount
    Via Benzinga
    Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    AMC Networks, Louisiana-Pacific And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
    Via ACCESSWIRE
    Evotec SE: Results of the Annual General Meeting 2024
    Via ACCESSWIRE
    Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases
    Via ACCESSWIRE
    Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington’s Disease
    Via ACCESSWIRE
    EVO Stock Earnings: Evotec Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Evotec SE to Announce Results for First Quarter 2024 on 22 May 2024
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.